[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ufuk University\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":95},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,49,73],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":31,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100617556","the-effect-of-hpv-education-provided-to-women-on-their-knowledge-levels-hpv-screening-and-vaccination-uptake-100617556",false,"NCT07320157","The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake","\"Women's HPV Education and Its Effects on Knowledge Levels, HPV Screening Behaviors, and HPV Vaccination Uptake: An Interventional Education Study\"","HPV-Education","Inclusion Criteria:\n\n* Being female\n* Women aged 18-35 years\n* Ability to speak and understand Turkish at a level sufficient to communicate with the researcher\n* Having the technical equipment necessary to participate in a video interview\n* No diagnosis of HPV positivity\n* Not having received the HPV vaccine\n* Not having undergone HPV DNA\u002FPap smear testing in the past 5 years\n* No diagnosis of cervical cancer\n* Voluntary willingness to participate in the study\n* No diagnosis of a psychiatric disorder\n\nExclusion Criteria:\n\n* Being male\n* Having severe physical or cognitive impairments that prevent completing the questionnaire\n* Being under 18 years of age or over 35 years of age\n* Inability to speak or understand Turkish\n* Lack of technical equipment to participate in a video interview\n* Having a diagnosis of HPV positivity\n* Having received the HPV vaccine\n* Having undergone HPV DNA\u002FPap smear testing in the past 5 years\n* Having a diagnosis of cervical cancer\n* Having a diagnosed psychiatric disorder\n\nNot agreeing to participate in the study",true,"FEMALE","18 Years","35 Years",{"count":22,"type":23},64,"ESTIMATED","INTERVENTIONAL",[26],"NA","Type of Study: This study was planned to be an observational study.\n\nPurpose of the Study: To evaluate the impact of HPV education given to women on their knowledge levels and HPV screening and vaccination.The main question\\[s\\] it aims to answer \\[is\u002Fare\\]:\n\nH1: There is a difference in the mean Human Papillomavirus (HPV) Knowledge Scale score between the intervention group women who participated in Human Papillomavirus (HPV) education and the control group women.\n\nH2: There is a difference between the intervention group women and the control group women in terms of their participation in HPV screening tests.\n\nH2: There is a difference between the intervention group women and the control group women in terms of their HPV vaccination status.\n\nParticipants Participants will be assigned to a control and intervention group. Online training will be provided to the intervention group, and the results of the training will be reported.",[29,30],"HPV (Human Papillomavirus)-Associated","HPV Immunization Status",[32,33,34,35],"HPV","WOMEN","HEALTH","VACCİNE","RECRUITING","2026-01-20",{"date":39,"type":40},"2026-01-22","ACTUAL",{"date":42,"type":40},"2026-01-09",{"date":44,"type":23},"2026-04-03",{"name":46,"class":47},"Ufuk University","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":59,"phases":4,"briefSummary":60,"conditions":61,"keywords":4,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":48},"100607491","evaluation-of-fibromyalgia-frequency-and-pain-parameters-in-women-with-polycystic-ovary-syndrome-100607491","NCT07189247","Evaluation of Fibromyalgia Frequency and Pain Parameters in Women With Polycystic Ovary Syndrome","Evaluation of Fibromyalgia Frequency and Pain Parameters in Women With Polycystic Ovary Syndrome: A Prospective Single-Blind Study","Inclusion Criteria:\n\n1. Women aged 18-40\n2. Those diagnosed with Polycystic Ovary Syndrome by a Gynecologist and Obstetrician (according to the Rotterdam Criteria)\n3. Those who agreed to participate in the study and signed the informed consent form\n\nExclusion Criteria:\n\n1. Patients with underlying uterine or adnexal pathologies (endometrial polyps, adenomyosis, uterine fibroids, adnexal masses, etc.) identified by ultrasound\n2. Patients with previous pelvic surgery\n3. Secondary causes of hirsutism and oligomenorrhea (non-classical congenital adrenal hyperplasia, Cushing's syndrome, hypothyroidism, prolactinoma, androgen-synthesizing tumor)\n4. Pregnant women\n5. Patients with a history of muscular or rheumatological diseases\n6. Patients with uncontrolled diabetes\n7. Patients with severe psychiatric illnesses or a history of psychiatric medication\u002Fsubstance abuse","40 Years",{"count":58,"type":23},140,"OBSERVATIONAL","The primary objective was to determine the prevalence of fibromyalgia in women with PCOS and to examine the relationship between fibromyalgia and psychological status (depression and anxiety). Secondary objectives were to explore the potential link between fibromyalgia and insulin resistance, taking into account phenotypic differences. To assess the relationship between fibromyalgia severity and quality of life and pressure pain threshold measurements. To analyze the impact of pain and mood disorders on PCOS phenotypes and to demonstrate the role of insulin resistance in predicting fibromyalgia.\n\nParticipants will be women aged 18-40 diagnosed with PCOS according to the Rotterdam criteria, and a healthy control group of a similar age. When making a PCOS diagnosis, clinical (hirsutism, acne, menstrual irregularity), biochemical (free testosterone, DHEAS, androstenedione, etc.), and ultrasonographic (polycystic ovary morphology) findings will be evaluated. The control group will consist of healthy volunteers presenting with gynecological complaints other than PCOS and without chronic diseases.\n\nExamination and Assessment Process Obstetrics and Gynecology Outpatient Clinic: PCOS diagnosis, demographic data, biochemical tests (glucose, insulin, HOMA-IR, etc.), and phenotyping.\n\nPhysical Therapy and Rehabilitation: Application of the 2016 ACR fibromyalgia criteria in a single-blind trial, including measurement of pressure pain threshold (algometer), fibromyalgia severity scale, and recording of Fibromyalgia Impact Questionnaire scores.\n\nPsychological Assessment The HADS (Hospital Anxiety and Depression Scale) will be administered to assess depression and anxiety levels.\n\nScores obtained will be compared with fibromyalgia diagnosis and PCOS phenotypes to examine the influence of psychological factors on pain perception.",[62,63],"Fibromyalgia","PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","NOT_YET_RECRUITING","2025-09-16",{"date":67,"type":40},"2025-09-23",{"date":69,"type":23},"2025-11-01",{"date":71,"type":23},"2026-11-01",{"name":46,"class":47},{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":56,"enrollmentInfo":79,"targetDuration":4,"studyType":59,"phases":4,"briefSummary":81,"conditions":82,"keywords":84,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":48},"100562720","assessment-of-the-uterus-using-ultrasonographic-elastography-in-women-with-dysmenorrhea-100562720","NCT06606834","Assessment of the Uterus Using Ultrasonographic Elastography in Women with Dysmenorrhea","Inclusion Criteria:\n\n1. Women aged 18-40 years.\n2. Women with primary dysmenorrhea who are willing to participate in the study.\n3. Women without primary or secondary dysmenorrhea who agree to participate as a control group.\n\nExclusion Criteria:\n\n1. Women with secondary dysmenorrhea.\n2. Patients with underlying uterine or adnexal pathologies (e.g., endometrial polyps, adenomyosis, uterine fibroids, adnexal masses, ovarian pathologies and cysts) identified via ultrasonography.\n3. Individuals with a history of uterine surgery.\n4. Individuals with a history of pelvic surgery.\n5. Individuals who have delivered via normal spontaneous vaginal delivery or cesarean section.",{"count":80,"type":23},100,"The aim of this study is to perform sonoelastographic assessment of the uterus in patients diagnosed with primary dysmenorrhea and to compare these measurements with sonoelastographic evaluations of the uteri in asymptomatic individuals. This will enable, for the first time, the demonstration of whether the elasticity of the myometrial tissue contributes to the etiology of primary dysmenorrhea.\n\nSecondary Objectives: To determine whether there is a correlation between the severity of primary dysmenorrhea and ultrasonographic markers.",[83],"Primary Dysmenorrhea",[85,86],"Dysmenorrhea","Sonoelastography","2024-09-19",{"date":89,"type":40},"2024-09-23",{"date":91,"type":23},"2024-09-20",{"date":93,"type":23},"2025-06-15",{"name":46,"class":47},""]